Literature DB >> 8259419

Soft-tissue tumors: diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy.

H Kobayashi1, H Sakahara, M Hosono, M Shirato, K Endo, Y Kotoura, T Yamamuro, J Konishi.   

Abstract

PURPOSE: To assess the potential of technetium-99m (V) dimercaptosuccinic acid (DMSA) scintigraphy for diagnosis of soft-tissue tumors.
MATERIALS AND METHODS: Tc-99m (V) DMSA scintigraphy was performed in 76 patients with histologic proof of soft-tissue tumors. In 57 of these patients, gallium-67 citrate scintigraphy was performed within 2 weeks after Tc-99m (V) DMSA scintigraphy.
RESULTS: Uptake of Tc-99m (V) DMSA was clearly detected in almost all sarcomas, metastatic carcinomas, highly recurrent benign tumors (ie, extra-abdominal desmoids and tenosynovial giant cell tumors), superficial and deep hemangiomas, and granulomatous soft-tissue lesions but was not found in other benign solid tumors of soft tissue. Uptake of Ga-67 citrate was clearly detected in all inflammatory lesions and metastatic carcinomas, eight of 14 sarcomas (57%), and two of 10 highly recurrent benign tumors (20%) but was not found in hemangiomas or benign soft-tissue tumors.
CONCLUSION: Low-grade malignant and highly recurrent benign lesions, which often recur after surgery, were detected more accurately with Tc-99m (V) DMSA scintigraphy than with Ga-67 citrate scintigraphy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8259419     DOI: 10.1148/radiology.190.1.8259419

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

Review 1.  Role of scintigraphy in inflammatory bowel disease.

Authors:  Maria I Stathaki; Sophia I Koukouraki; Nikolaos S Karkavitsas; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

2.  In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.

Authors:  A S Lam; M R Puncher; P J Blower
Journal:  Eur J Nucl Med       Date:  1996-12

3.  Evaluation of Tc-99m(V) DMSA for imaging inflammatory lesions: an experimental study.

Authors:  M T Ercan; N C Gülaldi; I S Unsal; M Aydin; I Peksoy; Z Hasçelik
Journal:  Ann Nucl Med       Date:  1996-11       Impact factor: 2.668

4.  Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.

Authors:  H Kobayashi; K H Suzuki; H Sakahara; Z S Yao; A Yokoyama; J Konishi
Journal:  Eur J Nucl Med       Date:  1995-06

5.  Solitary muscular sarcoidosis: CT, MRI, and scintigraphic characteristics.

Authors:  H Kobayashi; Y Kotoura; H Sakahara; T Yamamuro; K Endo; J Konishi
Journal:  Skeletal Radiol       Date:  1994-05       Impact factor: 2.199

6.  Uptake of pentavalent technetium-99m dimercaptosuccinic acid in idiopathic synovial chondromatosis.

Authors:  H Kobayashi; Y Kotoura; M Hosono; T Tsuboyama; N Nishijima; H Sakahara; J Konishi
Journal:  Ann Nucl Med       Date:  1995-08       Impact factor: 2.668

7.  Skeletal affinity of Tc(V)-DMS is bone cell mediated and pH dependent.

Authors:  Kazuko Horiuchi-Suzuki; Aya Konno; Mayumi Ueda; Yoko Fukuda; Saori Nishio; Kazuyuki Hashimoto; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11-29       Impact factor: 9.236

8.  (99m)Tc-DMSA (V) in Evaluation of Osteosarcoma: Comparative Studies with (18)F-FDG PET/CT in Detection of Primary and Malignant Lesions.

Authors:  G P Bandopadhyaya; Priyanka Gupta; Archana Singh; Jaya Shukla; S Rastogi; Rakesh Kumar; Arun Malhotra
Journal:  ISRN Oncol       Date:  2012-05-07

9.  Functional imaging techniques for evaluation of sarcomas.

Authors:  Rodney J Hicks
Journal:  Cancer Imaging       Date:  2005-06-21       Impact factor: 3.909

Review 10.  Dimercaptosuccinic acid: A multifunctional cost effective agent for imaging and therapy.

Authors:  Jaya Shukla; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.